001540.KQ

Equity

AHN-GOOK PHA

Health Care · Drug Manufacturers - Specialty & Generic

$8,070.00

+8,070.00 (+0.00%)

Open

N/A

Day Range

$7,950.00 - $8,170.00

52W Range

$6,230.00 - $9,400.00

Volume

154K

Price History

Key Statistics

Market Cap

N/A

P/E Ratio

N/A

EPS

N/A

Dividend Yield

N/A

P/B Ratio

N/A

Payout Ratio

N/A

ROE

N/A

Debt/Equity

N/A

Institutional Ownership

0.2% Institutional 48.2% Insider 51.6% Public

Latest News

RingCentral to Present at Morgan Stanley Investor Conference

Business Wire 2 hours ago

Algoma Central Corporation Announces Agreement to Acquire Lower Lakes Fleet

Business Wire 2 hours ago

CoreWeave to Participate in Upcoming Morgan Stanley TMT and Cantor Global Technology Investor Conferences

Business Wire 2 hours ago

Aardvark Therapeutics Announces Voluntary Pause of Phase 3 HERO Trial in Prader-Willi Syndrome

GlobeNewswire 2 hours ago

Tidewater Utilities Announces Customer Bill Credit Using PFAS Litigation Proceeds

GlobeNewswire 2 hours ago

Peers in Health Care

Symbol Name Price Mkt Cap Div Yield Change
ABT Abbott Laboratories $116.32 N/A 2.06% +0.00%
LLY Eli Lilly and Company $1,052.20 N/A 0.59% +0.00%
NVO Novo Nordisk A/S $37.46 N/A 4.49% +0.00%
EJG.F EBOS Group Ltd. R $11.70 N/A 5.14% +0.00%
5889.T JAPAN EYEWEAR HOLDINGS CO LTD $1,998.00 N/A 4.20% +0.00%
0332.KL TOPVISN $0.17 N/A 11.76% +0.00%
CUV.AX CLINUVEL FPO [CUV] $10.01 N/A 0.50% +0.00%
ABBV AbbVie Inc. $230.81 N/A 2.88% +0.00%

Community Sentiment

Sign in to vote

0% Bullish 0% Neutral 100% Bearish

0 votes

Discussion (0)

Sign in to join the discussion

Loading comments...

About AHN-GOOK PHA

Ahn-Gook Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products. The company's pharmaceutical products include Cinatura and Revo Tension. The company was founded in 1959 and is headquartered in Seoul, South Korea.

www.ahn-gook.com →

Dividend Safety

Assessment based on payout ratio, debt levels, profit margins, and dividend growth track record.

60

Safe

Based on 4 fundamental factors

+ 9 years of growth

Analysis Tools

Sign in for analysis tools

Share